Femoxetine

Femoxetine
Systematic (IUPAC) name
(3R,4S)-3-[(4-methoxyphenoxy)methyl]-1-methyl-4-phenyl-piperidine
Clinical data
Pregnancy cat.  ?
Legal status Uncontrolled
Routes Oral
Pharmacokinetic data
Half-life 7-27 hours
Identifiers
CAS number 59859-58-4
ATC code None
PubChem CID 3012003
ChemSpider 2280941 Y
UNII 8Y719ZLX8C Y
ChEMBL CHEMBL94739 Y
Chemical data
Formula C20H25NO2 
Mol. mass 311.42 g/mol
SMILES eMolecules & PubChem
 Y(what is this?)  (verify)

Femoxetine (Malexil, FG-4963) is a drug related to paroxetine that was being developed as an antidepressant by the pharmaceutical company Ferrosan in 1974. It functions as a selective serotonin reuptake inhibitor (SSRI). Development was halted for unknown reasons, perhaps to focus attention on paroxetine instead.

Dr. Jorgen Buus-Lassen of Ferrosan invented both femoxetine and paroxetine in the 1970s.[1]

References